MY ACCOUNT | NEWSLETTER |

Gilad&Gilad Launches Agmavet® for Horses for Promoting Resilient Nerve Functions and Joints Mobility


From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine®, Gilad&Gilad is excited to announce the launch of AgmaVet® For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort.

Osteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. It affects some 30-50% of dogs, cats and horses. In horses, its annual impact is as high as $1 billion.

Scientific evidence indicates that improper nerve functions underlie the tremendous discomfort caused by deteriorating OA health. This explains why existing treatments to maintain joint health are of limited effect and yield inconsistent results. “There is a clear unmet need for safe and effective natural dietary products that can relieve aches and leg weakness by promoting both resilient nerve functions and proper joints mobility," said Dr. Gad M. Gilad, CEO of Gilad&Gilad.

Gilad&Gilad developed AgmaVet® For Horses based on substantial scientific research and clinical trials. A recently published clinical trial has demonstrated that G-Agmatine® can improve OA-associated lameness as well as protect horses from developing gastric ulcers, a serious side effect of existing treatments (J. Clin. Med. 2022, 11(24), 7283).

AgmaVet® For Horses together with AgmaVet® (for small animals) and AgmaSet® belong to the Agmaceuticals® line of patent protected products containing the neuroprotective ingredient G-Agmatine®. These category-leading products are superior to existing therapies for sustaining resilient nerve functions and proper joints mobility.

You are Invited to upcoming showcases of AgmaVet® For Horses:

- WVC Conference (February 16-18, 2026, in Las Vegas) – Booth #821

- Natural Product Expo West (March 16-18, 2026, in Anaheim) – Booth #3673

About Gilad&Gilad

Gilad&Gilad is a health science company with core competencies in Neuroscience, largely invested in R & D. The Company developed the exclusive Agmaceuticals® product line based on its founders’ discovery of the neuroprotective properties of the natural molecule Agmatine. G-Agmatine® is the best brand of premium grade agmatine. Agmatine usage for supporting nerve health and joint mobility is patented (US patents: 8,916,612; 9,585,852; 11,622,949; 11,877,990).


Source: https://ForNerveHealth.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Joyful send-off for legendary biomedical sciences professor

Like0
Dislike0

Nonhypotensive autonomic agents in veterinary ophthalmology

Like0
Dislike0

Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology

Like0
Dislike0

Probiotics and its potential role in poultry production: A review

Like0
Dislike0

How a Better Bile Acid Could Keep C. diff at Bay

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top